JPRN-UMIN000002744已完成未知
Success of tocilizumab in RA patients with remission induction and sustained efficacy after discontinuation - Surprise study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients whose Steinbrocker functional classification are class 4 2) Patients treated with leflunomide, disease modifying anti-rhuematic disease drugs without methotrexate, or tacrolimus 3) Patients who have ever treated with any of biologic agents 4) Patients treated with 10mg/day of predonisolone 5) Patients whose WBC is less than 4000 or lymphocytes is less than 1000 6) Patients with infection of HBV or EBV
研究者
相似试验
已完成
不适用
Efficacy and safety of tocilizumab in RA patients in daily clinical practice: An retrospective observational studyRheumatoid ArthritisJPRN-UMIN000006956niversity of Occupational and Environmental Health, Japan250
已完成
不适用
To investigate the efficacy of tocilizumab in RA patients with moderate disease activity under biologic therapyRheumatoid ArthritisJPRN-UMIN000010033Daihei Kida20
进行中（未招募）
1 期
Safety and efficacy study of tocilizumab injected under the skin in patients with active rheumatoid arthritis (RA) and inadequate response to disease modifying antirheumatic drugs.MedDRA version: 18.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2013-002007-34-FIRoche a/s137
进行中（未招募）
1 期
Safety and efficacy study of tocilizumab injected under the skin in patients with active rheumatoid arthritis (RA) and inadequate response to disease modifying antirheumatic drugs.Rheumatoid ArthritisEUCTR2013-002007-34-SERoche a/s137
进行中（未招募）
1 期
Safety and efficacy study of tocilizumab injected under the skin in patients with active rheumatoid arthritis (RA) and inadequate response to disease modifying antirheumatic drugs.Rheumatoid ArthritisEUCTR2013-002007-34-DKRoche a/s137